| 000 | 01196 a2200289 4500 | ||
|---|---|---|---|
| 005 | 20250512134949.0 | ||
| 264 | 0 | _c19680112 | |
| 008 | 196801s 0 0 eng d | ||
| 022 | _a0002-9629 | ||
| 024 | 7 |
_a10.1097/00000441-196711000-00017 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aSanders, E | |
| 245 | 0 | 0 |
_aUse of sulfonamide carbonic anhydrase inhibitors in treatment of meningococcal carriers: rationale and report of a clinical trial of ethoxzolamide. _h[electronic resource] |
| 260 |
_bThe American journal of the medical sciences _cNov 1967 |
||
| 300 |
_a709-16 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 |
_aCarbonic Anhydrase Inhibitors _xtherapeutic use |
| 650 | 0 | 4 |
_aCarrier State _xdrug therapy |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aIn Vitro Techniques |
| 650 | 0 | 4 |
_aMeningococcal Infections _xdrug therapy |
| 650 | 0 | 4 |
_aNeisseria meningitidis _xdrug effects |
| 650 | 0 | 4 |
_aSulfadiazine _xpharmacology |
| 650 | 0 | 4 |
_aSulfonamides _xpharmacology |
| 773 | 0 |
_tThe American journal of the medical sciences _gvol. 254 _gno. 5 _gp. 709-16 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1097/00000441-196711000-00017 _zAvailable from publisher's website |
| 999 |
_c4967001 _d4967001 |
||